Fortis Healthcare’s arm to sell entire 79.43% stake in LHPL

19 Aug 2017 Evaluate

Fortis Healthcare’s step down subsidiary - Fortis Cancer Care (FCCL) has entered into a Memorandum of Understanding (MoU) with Lalitha Healthcare (LHPL), another step down subsidiary of the company, Dr. Lakshmi Narayana Raju, Lakshmi Priya, S. Venkataramana Raju (collectively the Promoters of LHPL) and Anikrish Hospitals for sale of the entire shareholding held by FCCL, representing 79.43% of the total issued and paid up equity share capital of LHPL, to the Promoters of LHPL.

The MoU contemplates that FCCL, LHPL and the Promoters of LHPL will enter into a share purchase agreement (SPA) for the sale of the FCCL Shares to the Promoters of LHPL. Pursuant, to the consummation of the Proposed Transaction the control and management of LHPL will be transferred to the Promoters of LHPL.

Fortis Healthcare is an integrated healthcare delivery service provider in Asia. The healthcare verticals of the company span primary care, diagnostics, day care specialty and hospitals, with a healthcare network spanning 9 countries.

Fortis Healthcare Share Price

444.50 3.00 (0.68%)
23-Apr-2024 15:40 View Price Chart
Peers
Company Name CMP
Aster DM Healthcare 399.40
Apollo Hospital Ent. 6181.40
Max Healthcare Inst 760.35
Narayana Hrudayalay 1247.00
Global Health 1416.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.